Type I (RI) and type II (RII) receptors for transforming growth factor- β isoforms are expressed subsequent to transforming growth factor-β ligands during excisional wound repair

American Journal of Pathology

Volumn 150, Issue 1, 1997, Pages 209-222

  Gold, Leslie I ^a   Sung, Joanne J ^a   Siebert, John W ^a   Longaker, Michael T ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; MEMBRANE PROTEIN; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; EXTRACELLULAR MATRIX; GROWTH REGULATION; IMMUNOREACTIVITY; IMMUNOREGULATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SHEEP; SIGNAL TRANSDUCTION; WOUND HEALING;

ANIMALS; LIGANDS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SHEEP; SKIN; STAINING AND LABELING; STEREOISOMERISM; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 0031013030     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Massague J, Attisano L, Wrana JL: The TGF-β family and its composite receptors. Trends Cell Biol 1994, 4:172-178
2. Wahl SM: Transforming growth factor β (TGF-β) in inflammation: a cause and a cure. J Clin Immunol 1992, 12:61-74
3. Roberts AB, Sporn MB: Physiological actions and clinical applications of transforming growth factor-β (TGFβ). Growth Factors 1993, 8:1-9
4. Kingsley D: The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994, 8:133-146
5. Wrana JL, Atttsano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massague J: TGF-β signals through a heteromeric protein kinase receptor complex. Cell 1992, 71:10003-10014
6. Lin HY, Lodish HF: Receptors for the TGF-β superfamily: multiple polypeptides and serine/threonine kinases. Trends Cell Biol 1993, 3:14-19
7. Ebner R, Chen RH, Shum L, Lawler S, Zionchek TF, Derynck R: Determination of type I receptor specificity by the type II receptors for TGF-β or activin. Science 1993, 262:900-902
8. Attisano L, Carcamo J, Ventura F, Weis FM, Massague J, Wrana JL: Identification of human activin and TGF-β type I receptors that form heteromeric kinase complexes with type II receptors. Cell 1993, 75:671-680
9. ten Dijke P, Ichijo H, Franzen P, Schulz P, Saras J, Toyoshima H, Heldin CH, Miyazono K: Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene 1993, 8:2879-2887
10. ten Dijke P, Yamashita H, Ichijo H, Laiho M, Miyazono K, Heldin CH: Characterization of type I receptors for transforming growth factor-β and activin. Science 1994, 264:101-104
11. Segarini PR, Rosen DM, Seyedin SM: Binding of TGF-β to cell surface proteins varies with cell type Mol Endocrinol 1989, 3:261-272
12. Cheifetz S, Hernandez H, Laiho M, ten Dijke P, Iwata KK, Massague J: Distinct transforming growth factor-β (TGF-β) receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J Biol Chem 1990, 265:20533-20538
13. Miyazono K, Ichijo H, Heldin CH: Transforming growth factor-β: latent forms, binding proteins, and receptors. Growth Factors 1993, 8:11-22
14. Massague J: Receptors for the TGF-β family. Cell 1992, 69:1067-1070
15. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF: Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 1992, 68:775-785
16. Wang XF, Lin HY, Ng-Eaton E, Downward J, Lodish HF, Weinberg RA: Expression cloning and characterization of the TGF-β type III receptor. Cell 1991, 67:797-805
17. Franzen P, ten Dijke P, Ichijo H, Yamashita H, Schlz P, Heldin CH, Miyazono K: Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell 1993, 75:681-692
18. Lopez-Cassilas F, Wrana JL, Massague J: β-Glycan presents ligand to the TGF-β signaling receptor. Cell 1993, 73:1435-1444
19. Chen F, Weinberg, RA: Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor β receptor kinases. Proc Natl Acad Sci USA 1995, 92:1565-1569
20. Lui F, Hata A, Baker JC, Doody J, Carcamo J, Harland RM, Massague J: A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 1996, 381:620-623
21. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J: Mechanism of activation of the TGF-β receptor. Nature 1994, 370:341-347
22. Lin HY, Moustakas A, Knaus P, Wells RG, Henis YI, Lodish HF: The soluble exoplasmic domain of the type II transforming growth factor (TGF)-β receptor: a heterogeneously glycosylated protein with high affinity and selectivity for TGF-β ligands. J Biol Chem 1995, 270:2747-2754
23. Border WA, Ruoslahti E: Transforming growth factor-β in disease; the dark side of tissue repair. J Clin Invest 1992, 90:1-7
24. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH: Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor-β. J Exp Med 1987, 165:251-256
25. Quaglino D, Nanney LB, Kennedy R, Davidson JM: Transforming growth factor-β stimulates wound healing and modulates extracellular matrix gene expression in pig skin. I, Excisional wound model. Lab Invest 1990, 63:307-319
26. Quaglino D, Nanney LB, Ditesheim JA, Davidson JM: Transforming growth factor βstimulates wound healing and modulates extracellular matrix gene expression in pig skin: incisional wound model. J Invest Dermatol 1991, 97:34-42
27. Roberts AB, Sporn MB, Assoian RK: Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation In vitro. Proc Natl Acad Sci USA 1986, 83:788-798
28. Ellis I, Grey AM, Schor AM, Schor SL: Antagonistic effects of TGF-β1 and MSF on fibroblast migration and hyaluronic acid synthesis. J Cell Sci 1992, 102:447-456
29. Leiho M, Saksela O, Keski-Oja J: Transforming growth factor-β induction of type I plasminogen activator inhibitor. J Biol Chem 1987, 262:17467-17474
30. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 1994, 331:1286-1292
31. Raghow R: the role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J 1994, 8:823-831
32. Santana A, Saxena B, Nobel NA, Gold LI, Marshall BC: Increased expression of transforming growth factor β isoforms (β1, β2, β3) in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 1995, 13:34-44
33. Yamamoto T, Nobel NA, Cohen AH, Hishida A, Gold LI, Border WA: Expression of transforming growth factor-β isoforms in human glomerular disease, Kidney Int 1996, 49:461-469
34. Gold LI, Saxena B, Colby TV, McDonald JA: Immunohistochemical localization and mRNA expression of TGF-β1, TGF-β2, and TGF-β3 in the normal lung and in idiopathic pulmonary fibrosis, J Cell Biochem 1993, 17E: (R502)136
35. McMullen HF, Longaker MT, Cabrera RC, Sung JJ, Canete J, Siebert JW, Lorenz HP, Gold LI: Analysis of TGF-β1, TGF-β2, and TGF-β3 immunoreactivity during ovine wound repair. Wound Repair Regen 1995, 3:141-156
36. Ghahary A, Shen YJ, Scott PG, Gong Y, Tredget EE: Enhanced expression of mRNA for transforming growth factor-β, type I and type III procollagen in human postburn hypertrophie scar tissues, J Lab Clin Med 1993, 122:465-473
37. Levine JH, Moses HL, Gold LI, Nanney LB: Spatial and temporal patterns of immunoreactive transforming growth factor-β1, -β2, and -β3 during excisional wound repair. Am J Pathol 1993, 143:368-380
38. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI: Immunohistochemical localization of TGF-β1, TGF-β2, and TGF-β3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 1991, 115:1091-1095
39. Gold LI, Saxena B, Mittal K, Goswami S, Korc M, Demopoulos RI: Increased expression of TGF-β3 isoforms and bFGF in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Cancer Res 1994, 54:2347-2357
40. Kimichi A, Wang XF, Weinberg RA, Cheifetz S, Massague J: Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells. Science 1988, 240:196-198
41. Igarashi A, Okochi H, Bradham DM, Grotendorst GR: Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993, 4:637-645
42. Schmid P, Kunz S, Cerletti N, McMaster G, Cox D: Injury induced expression of TGF-β1 mRNA is enhanced by exogenously applied TGF-βs. Biochem Biophys Res Commun 1993, 194:399-406
43. Pierce GF, Tarpley JE, Yanagihara D, Mustoe TA, Fox GM, Thomason A: Platelet-derived growth factor (BB homodimer), transforming growth factor-β1, and basic fibroblast growth factor in dermal wound healing: neovessel and matrix formation and cessation of repair, Am J Pathol 1992, 140:1375-1388
44. Beck IS, Chen TL Mikalauski P, Ammann AJ: Recombinant human transforming growth factor-β1 (rhTGFβ1) enhances healing and strength of granulation skin wounds. Growth Factors 1990, 3:267-275
45. Kane CJM, Hebda PA, Mansbridge JN, Hanawait PC: Direct evidence for spatial regulation of transforming growth factor β1 expression during cutaneous wound healing. J Cell Physiol 1991, 148:157-173
46. Sporn MB, Roberts AB: Transforming growth factor-β: recent progress and new challenges. J Celi Biol 1992, 119:1017-1021
47. Heine J, Ignotz RA, Hemler ME, Grouse C, Massague J: Regulation of cell adhesion receptors by transforming growth factor-β: concomitant regulation of integrins that share a common β1 subunit. J Biol Chem 1989, 264:380-388
48. Zambruno G, Marchisio PC, Marconi A, Vaschieri C, Melchiori A, Giannett A, De Luca M: Transforming growth factor-β1 modulates β1 and β5 integrin receptors and induces the de novo expression of the aVβ6 heterodimer in normal human keratinocytes: implication for wound healing, J Cell Biol 1995, 129:853-865
49. Pietenpol JA, Holt JT, Stein RW, Moses HL: Transforming growth factor β1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci USA 1990, 87:3758-3762
50. Ebner R, Chen RH, Shum L, Lawler S, Zionchek TF, Lee A, Lopez AR, Derynck R: Cloning of a type I TGF-β receptor and its effects on TGF-β binding to the type II receptor. Science 1993, 260:1344-1348
51. Bassing CH, Yingling JM, Howe DJ, Wang T, He WW, Gustafson ML, Shah P, Donahoe PK, Wang XF: A transforming growth factor β type I receptor that signals to activate gene expression. Science 1994, 263:87-89
52. Matsura H, Myokii F, Arata J, Noji S, Taniguchi S: Expression of type II transforming growth factor-β receptor mRNA in human skin, as revealed by in situ hybridization. J Dermatol Sci 1994, 8:25-32
53. Reibman J, Meixler S, Lee T, Gold LI: Cronstein B, Haines K, Weissmann G: Transforming growth factor β1, a potent chemoattractant for human neutrophils, bypasses classic signal transduction pathways. Proc Natl Acad Sci USA 1991, 88:6805-6809
54. Parekh T, Saxena B, Reibman J, Cronstein B, Gold LI: Neutrophil chemotaxis in response to transforming growth factor-β isoforms (TGF-β1, TGF-β2, and TGFβ3) is mediated by fibronectin, J Immunol 1994, 152:2456-2466
55. Taipale J, Koli K, Keski-Oja J: Release of transforming growth factor-β1 from the pericellular matrix of cultured human fibrobiasts and fibrosarcoma cells by plasmin and thrombin, J Biol Chem 1992, 267:25378-25385
56. Gailit J, Clark RAF: Wound repair in context of extracellular matrix, Curr Opin Cell Biol 1994, 6:717-725
57. Van De Water L, Reimer C, Plantefaber L, Hynes RO, Peters JH: Fibronectins that include the EDIIIA segment are deposited in a restricted temporal pattern during cutaneous wound healing and promote the differentiation of fibrobiasts in culture. 1995 Keystone Symposia Abstracts "Tissue engineering and wound repair in context"
58. Balza, E, Borsi L, Allemani G, Zardi L: Transforming growth factor β regulates the levels of different fibronectin isoforms in normal human cultured fibrobiasts. FEBS Lett 1988, 228:42-44
59. Allen-Hoffmann BL, Crankshaw CL, Mosher DF: Transforming growth factor β increases cell surface binding and assembly of exogenous (plasma) fibronectin by normal human fibrobiasts. Mol Cell Biol 1988, 8:4234-4242
60. Brandes ME, Mai UEH, Ohura K, Wahl SM: Type I transforming growth factor receptors on neutrophils mediate chemotaxis to transforming growth factor-β. J Immunol 1991, 147:1600-1606
61. Chen RH, Ebner R, Derynck R: Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 1993, 260:1335-1338
62. Takeuchi Y, Fukumoto S, Matsumoto T: Relationship between actions of transforming growth factor (TGF)-β and cell surface expression of its receptors in clonal osteoblastic cells. J Cell Physiol 1995, 162:315-321
63. Miettinen PJ, Ebner R, Lopez AR, Derynck R: TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors, J Cell Biol 1994, 127:2021-2036
64. Shah M, Foreman DM, Ferguson MWJ: Neutralization of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995, 108:985-1002
65. Bouhana KS, Longaker MT, Banda MJ, Roberts AB, Lorenz HP, Whitby DJ, Weatherbee JA, Dvorak HF: In vivo analysis of TGF-β isoforms injected individually and in combinations, Surg Forum 1995 XLV:751-752
66. Perkett EA, Peiton Rw, Meyrick B, Gold LI: Miller DA: Expression of transforming growth factor-β mRNAs and proteins in pulmonary vascular remodeling in the sheep air embolization model of pulmonary hypertension. Am J Respir Cell Mol Biol 1994, 11:16-24
67. Piedbouf B, Gold LI, Sung JJ, Kazzaz J, Horowitz S: complex regulation of transforming growth factor β isoforms in hyperoxic lung. Pediatr Res 1995, 37:345A